文献速递皮肤肿瘤银屑病与炎症性皮肤病

皮肤病患者完成自杀风险的系统综述与荟萃分析

Completed suicide in patients with skin disease: A systematic review and meta-analysis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2025-03-17

该系统综述与荟萃分析纳入37项研究,其中17项高质量人群研究(3,800,748例皮肤病患者,33,722,675+对照)分析13种皮肤病与完成自杀的关系。黑色素瘤(SMR 2.89)、非黑色素瘤皮肤癌女性(SMR 1.30)和化脓性汗腺炎(OR 2.86)与完成自杀风险增加相关,而银屑病和皮炎未发现显著关联。

要点

  • 黑色素瘤患者完成自杀风险显著升高(SMR 2.89)。
  • 化脓性汗腺炎与完成自杀正相关(OR 2.86)。
  • 银屑病和皮炎与完成自杀无显著关联。

核心结论

  • 治疗皮肤病患者时应考虑自杀倾向,尤其是化脓性汗腺炎和黑色素瘤患者。
  • 其他皮肤病与完成自杀的关联尚不明确,需进一步研究。

研究设计与样本

  • 系统综述与荟萃分析,检索Pubmed、Embase和PsycINFO数据库至2023年6月。
  • 纳入标准为英文原创研究、至少10例成人患者、评估皮肤病与自杀死亡的关系。
  • 共37项研究符合标准,荟萃分析纳入17项高质量人群研究,包括3,800,748例皮肤病患者和33,722,675+对照。
  • 采用随机效应模型,因预期存在研究间变异。
  • 识别出13种皮肤病,每种皮肤病分别分析。

主要发现

  • 银屑病:6项研究纳入荟萃分析,OR 1.42,95% CI (0.76; 2.68),无显著关联。
  • 皮炎:5项研究纳入荟萃分析,OR 1.54,95% CI (0.57; 4.17),无显著关联。
  • 黑色素瘤:4项研究纳入荟萃分析,SMR 2.89,95% CI (1.97; 3.81),显示关联。
  • 非黑色素瘤皮肤癌:2项研究纳入荟萃分析,女性患者SMR 1.30,95% CI (1.12; 1.49),风险增加。
  • 化脓性汗腺炎:2项研究纳入荟萃分析,OR 2.86,95% CI (1.56; 5.24),正相关。

临床怎么用

  • 对化脓性汗腺炎和黑色素瘤患者应评估自杀风险并考虑干预。
  • 对银屑病和皮炎患者,完成自杀风险未显示显著增加,但仍需关注自杀倾向。

局限性

  • 其他皮肤病与完成自杀的关联尚不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several skin diseases have been associated with suicidality. However, the term 'suicidality' encompasses ideation, which weakens the conclusions. In contrast, the much stronger endpoint of completed suicide and skin disease remains ambiguous. OBJECTIVES: To determine the risk of completed suicide in adult patients with skin diseases. METHODS: The Pubmed, Embase and PsycINFO databases were performed from inception up to June 2023. All original studies in English with a minimum of 10 adult patients that assessed the relationship between a skin disease and death by suicide, were eligible for inclusion. RESULTS: Thirty-seven met the inclusion criteria. Owing to expected interstudy variations, a random effects model was used. A total of 13 skin diseases were identified: 17 population-based high-quality studies, 3,800,748 patients with skin disease, and 33,722,675+ controls were included in the meta-analysis (MA). Each skin disease was analysed separately. Psoriasis: six studies were included in the MA (odds ratio (OR): 1.42, 95% confidence interval (CI) (0.76; 2.68) and found no association. Dermatitis: five studies were included in the MA OR: 1.54, 95% CI (0.57; 4.17) and found no association. Melanoma: four studies were included in the MA, which found an association between melanoma and suicide Standardized mortality rate (SMR): 2.89, 95% CI (1.97; 3.81). Non-melanoma skin cancer: two studies were included in the MA; female patients showed an increased risk of completed suicide compared to the control group SMR: 1.30, 95% CI (1.12; 1.49). In patients with hidradenitis suppurativa, two studies were included in the MA OR: 2.86, 95% CI (1.56; 5.24) and showed a positive association between HS and completed suicide. CONCLUSIONS: Suicidality should be considered by physicians when treating dermatological disease, especially when treating patients with hidradenitis suppurativa and melanoma. The association between other skin diseases and completed suicide remains unclear, and further research is indicated.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Hrvatin Stancic B, Henning MAS, Eriksen N, et al. Completed suicide in patients with skin disease: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2025. PMID: 40091608. doi:10.1111/jdv.20609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。